However, like all research compounds, it still carries risksespecially when improperly dosed, reconstituted, or sourced from unverified suppliers
The safety profile remains poorly characterized in humans, and no officially recognized clinical use exists
Sun Y, Sun M, Liu B, et al
Recalls & Warnings December 20, 2017 Seller of Supplements for Pain and Allergies Warned for Manufacturing Violations, Drug Claims On December 13, 2017, the FDA issued a warning letter to GnuPharma Corporation, following a facility inspection which found a number of the company's products, including Relief capsules, Foundation capsules, Aller-geez capsules, Fit capsules, Aller-Geez Tea, Foundation herbal tea and
During this phase, some users notice subtle energy improvements, particularly during fasted states